Companies: 10,795·Total market cap: $144.5T
Yubo International Biotech Limited

Yubo International Biotech Limited

YBGJOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1006454
P/E Ratio—
52W High$0.1776
52W Low$0.0079
Cash on HandFinancialsRevenue

Yubo International Biotech Limited (YBGJ) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

YBGJ · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$8,062▲ +14.9% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$8,062
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+14.9%
vs prior fiscal year
Latest Quarter
$10,382
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$8,062Cash on Hand
Total Debt$78,783Total Debt
Net Cash / Net Debt−$70,721Net Debt Position
Cash vs Debt Ratio
Cash 9%Debt 91%

Yubo International Biotech Limited carries a net debt position of $70,721. Total debt ($78,783) exceeds cash on hand ($8,062). Yubo International Biotech Limited cash vs debt ratio: 9% cash / 91% debt.

Net Cash = Cash & ST Investments − Total Debt$8,062 − $78,783 = −$70,721

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
YBGJ annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$0.0M+14.9%
Dec 31, 2024$0.0M-61.5%
Dec 31, 2022$0.0M-33.8%
Dec 31, 2021$0.0M-98.0%
Dec 31, 2020$1.4M+34463.1%
YBGJ cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Yubo International Biotech Limited
Yubo International Biotech LimitedYOU
YBGJ
$0.0M0.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Yubo International Biotech Limited (YBGJ) cash on hand as of December 31, 2025 is $8,062, comprising $8,062 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Yubo International Biotech Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as Yubo International Biotech Limited cash reserves or cash position.

Yubo International Biotech Limited annual cash on hand history shows increased +14.9% in 2025: increased +14.9% in 2025. Yubo International Biotech Limited cash reserves in 2025 reflect the company's capital allocation strategy.

Yubo International Biotech Limited carries total debt of $78,783 against cash of $8,062, resulting in a net debt position of -$70,721. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

YBGJ cash on hand · 5 questions

As of December 31, 2025, Yubo International Biotech Limited (YBGJ) has $8,062 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $8,062 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $10,382. Data sourced from the annual 10-K filing via FMP.

YBGJ cash on handYBGJ cash reservesYBGJ cash 2025how much cash does YBGJ have

▸ Source: FMP /balance-sheet-statement · US GAAP · Yubo International Biotech Limited · Yubo International Biotech Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025